Myringoplasty — Cost, Top Hospitals & Success Rates | MyMedicPlus

Myringoplasty is the surgical repair of a perforation (hole) in the tympanic membrane (eardrum) using a graft material to close the defect and restore the structural integrity of the middle ear sound-transmission mechanism. When the procedure is limited to repair of the tympanic membrane without ossicular reconstruction, it is classified as Wullstein Type I tympanoplasty — the most specific form of the broader tympanoplasty family of procedures.

The tympanic membrane is a thin, cone-shaped fibrous membrane approximately 9–10 mm in diameter that separates the external auditory canal from the middle ear. It plays a critical role in sound conduction: airborne sound waves set it in vibration, which is transmitted through the ossicular chain (malleus, incus, stapes) to the cochlea. A perforation disrupts this mechanism, typically causing a conductive hearing loss proportional to the size and location of the defect.

Perforations arise most commonly from:

• Chronic suppurative otitis media (CSOM): Recurrent middle ear infections that erode the eardrum over months to years
• Acute traumatic perforation: Barotrauma (pressure change during flying or diving), direct penetration, slap injury to the ear, or blast injury
• Post-tube extrusion: Failure of a tympanic membrane to heal after tympanostomy tube (grommet) extrusion

The goal of myringoplasty is threefold: to close the perforation and eliminate the risk of recurrent ear infections through the defect, to improve hearing by restoring the sound-conducting surface area of the tympanic membrane, and to protect the middle ear from water entry during bathing and swimming.

Myringoplasty is indicated for patients with a persistent tympanic membrane perforation that meets specific clinical criteria. The decision to proceed is based on a comprehensive assessment by an otologist or ENT surgeon.

Primary Indications

• Dry central tympanic membrane perforation: A perforation of the pars tensa with an intact annulus (rim), which has remained free of active infection and discharge (dry) for at least 3–6 months; these carry the best prognosis with success rates of 80–90%
• Symptomatic conductive hearing loss: Perforation causing a measurable air-bone gap (typically 15–40 dB in the affected frequencies) that affects daily communication, work, or quality of life
• Recurrent otorrhea (ear discharge): Repeated episodes of infection through the perforation, even if the ear is currently dry; closure eliminates the portal of entry for pathogens
• Water intolerance: Patients who cannot work or participate in water activities due to the risk of water contamination of the middle ear through the perforation
• Post-tube perforation: Persistent perforation following tympanostomy tube extrusion that has failed to heal spontaneously after 6–12 months

Situations Requiring Careful Evaluation Before Proceeding

• Active infection (wet ear): Myringoplasty should ideally not be performed on an actively discharging ear; a course of topical and/or systemic antibiotics to achieve a dry ear for 3–6 months is recommended before surgery
• Eustachian tube dysfunction: Impaired Eustachian tube function is one of the most important predictors of myringoplasty failure; preoperative assessment (Valsalva test, tympanometry) is essential; surgery on a non-functioning Eustachian tube carries significantly higher failure rates
• Cholesteatoma: The presence of cholesteatoma (epithelial ingrowth) upgrades the procedure to a more extensive tympanomastoid surgery; simple myringoplasty is not appropriate
• Single-hearing ear: Requires especially careful risk-benefit analysis, as any surgical complication could result in profound deafness in the only functional ear
• Pediatric patients: Generally a minimum age of 5 years (some surgeons prefer 7+ years) to allow Eustachian tube maturation and reduce the higher failure rate associated with immature Eustachian tube function in young children

A thorough preoperative assessment is essential to select appropriate candidates and optimize surgical outcomes. The following evaluations are standard:

Clinical Assessment

• Otoscopic examination: Characterize the perforation — location (anterior, posterior, inferior, central), size (small: less than 25%, medium: 25–50%, large: greater than 50% of drum area), and condition of the remnant drum and middle ear mucosa
• Eustachian tube function testing: The Valsalva maneuver (forced exhalation against a closed glottis and pinched nose) with otoscopic observation of drum movement confirms patency. Intact Valsalva is associated with better postoperative outcomes. Additional tests include the Toynbee maneuver and tympanometry with Eustachian tube assessment sequences
• Middle ear inspection: Check for middle ear granulations, polyps, or retraction pockets that may indicate underlying disease requiring more extensive management

Audiological Evaluation

• Pure-tone audiometry: Establishes the air-bone gap (ABG) — the difference between air conduction and bone conduction thresholds — which reflects the degree of conductive hearing loss attributable to the perforation. A large ABG (greater than 30 dB) often suggests co-existing ossicular chain pathology; if present, tympanoplasty with ossicular chain reconstruction rather than simple myringoplasty may be required
• Speech discrimination scores: Assesses functional hearing impact and expected benefit from surgical correction
• Acoustic reflex testing: Helps assess middle ear function and ossicular integrity

General Medical Assessment

• Fitness for anaesthesia (general for children; general or local for adults)
• Bleeding disorders or anticoagulant use requiring preoperative management
• Absence of active upper respiratory tract infection at the time of surgery (nasal congestion worsens Eustachian tube function in the perioperative period)
• Smoking history: smoking impairs wound healing and increases the risk of graft failure; cessation is advised before elective surgery

Modern myringoplasty is performed using one of several well-established surgical approaches and graft placement techniques. The choice depends on perforation size and location, surgical access, the operating surgeon's training, and institutional preference.

Graft Materials

• Temporalis fascia: The deep fascia of the temporalis muscle, harvested through a small incision above the ear; the most widely used graft material due to its fibrous strength, durability, and excellent take rate. It is the gold standard for medium and large perforations
• Tragal cartilage perichondrium: The fibrocartilaginous tissue from the tragus (the small anterior projection of the external ear); harvested through a small incision at the tragal margin. Perichondrium alone or cartilage-perichondrium composite grafts are used. Cartilage grafts are stronger and more rigid, conferring advantages for anterior perforations, revision surgeries, retraction-prone ears, or impaired Eustachian tube function where the graft must resist persistent negative pressure
• Fat graft myringoplasty: Adipose tissue (usually harvested from the lobule of the ear) packed into a small perforation (less than 2 mm); a simple, minimally invasive office-based procedure performed under local anaesthesia for very small traumatic perforations; success rates of 80–90% for carefully selected small perforations; not suitable for larger defects or infected ears

Surgical Approaches

• Endoscopic transcanal myringoplasty (ETCM): An entirely ear-canal approach using a 0-degree or 30-degree rigid endoscope introduced into the external auditory canal without any external incision. Advantages: no external scar, wide panoramic field of view, excellent visualization of the anterior annulus (traditionally a blind spot for microscopes in narrow canals), ambulatory procedure potential, and reduced surgical trauma. Growing in popularity with outcomes comparable to microscopic approaches for most perforations. Requires specific endoscopic otology training
• Microscopic post-auricular approach: A curved incision behind the ear (post-auricular) provides wide access to the tympanic membrane via a tympanomeatal flap; the gold-standard access for large perforations, revision cases, or cases where middle ear exploration is required; leaves a small post-auricular scar
• Microscopic endaural approach: An incision at the entrance of the ear canal between the tragus and helical root; intermediate access without a post-auricular incision; used for medium-sized perforations with adequate canal width

Graft Placement Techniques

• Underlay technique (medial graft): The graft is placed medial to (underneath) the tympanic membrane remnant and the annulus; the most commonly used technique worldwide; associated with high success rates, particularly for central and posterior perforations; avoids the risk of lateral displacement (blunting) seen with overlay
• Overlay technique (lateral graft): The graft is placed lateral to (on top of) the tympanic membrane remnant, with the squamous epithelium of the drum lifted off; historically used for anterior perforations and large defects; requires meticulous epithelial edge management to prevent inclusion cholesteatoma formation; higher technical demands
• Inlay (butterfly) technique: A cartilage graft shaped like a butterfly is wedged directly into the perforation without elevating a tympanomeatal flap; used for moderate-sized perforations; a quick, less invasive technique increasingly performed endoscopically as an office procedure in selected cases

When performed in appropriately selected patients by experienced otologists, myringoplasty offers substantial, durable benefits:

Primary Outcomes

• Graft take rate (closure of perforation): For dry central perforations with intact Eustachian tube function, overall success rates of 80–90% are consistently reported in peer-reviewed literature. Success rates are higher for posterior perforations (85–95%) and somewhat lower for anterior perforations (75–85%) due to more challenging access. Revision myringoplasty has lower success rates (60–80%)
• Hearing improvement: Successful graft closure typically reduces the air-bone gap by 10–20 dB on average. For large perforations with a pre-operative ABG of 30–40 dB, hearing improvement to near-normal levels (ABG less than 10–20 dB) is achievable in the majority of successful cases. Hearing gain is proportional to the size of the perforation closed
• Elimination of recurrent otorrhea: Successful closure eliminates the pathway for water and pathogens to enter the middle ear, dramatically reducing or eliminating episodes of recurrent otitis media with discharge
• Water intolerance resolution: Patients can return to swimming, bathing without ear protection, and aquatic activities after full healing (typically 3–6 months post-operatively)
• Prevention of long-term complications: Closing the perforation prevents the evolution toward more serious pathology including cholesteatoma formation, irreversible ossicular chain erosion, and chronic mastoiditis

Factors Influencing Success

• Good Eustachian tube function is the single most important predictor of graft take
• A dry (infection-free) ear for 3–6 months before surgery significantly improves outcomes
• Larger perforations have marginally lower success rates than smaller ones
• Anterior perforations are technically more challenging than posterior or central ones
• Cartilage grafts are associated with equivalent or slightly higher take rates compared to fascia in revision cases and high-risk ears
• Smoking and poorly controlled diabetes are associated with impaired wound healing and lower success rates

Myringoplasty is a safe surgical procedure with a well-established risk profile. All risks should be discussed with the operating surgeon at the preoperative consultation.

Procedure-Specific Risks

• Graft failure (perforation recurrence): The most common complication, occurring in 10–20% of primary cases; higher with large perforations, anterior perforations, impaired Eustachian tube function, or active infection. Revision surgery can be offered after a further dry period
• Hearing deterioration: A small risk (less than 1–2%) of worsening sensorineural hearing loss due to operative trauma; rare but irreversible. Particularly rare in straightforward transcanal endoscopic cases
• Tinnitus: New or worsened tinnitus may occasionally follow surgery; usually temporary
• Vertigo: Transient dizziness is common in the first 24–48 hours; persistent vertigo suggests labyrinthine disturbance and requires investigation
• Chorda tympani nerve injury: This nerve, which carries taste sensation to the anterior two-thirds of the tongue, passes through the middle ear and may require retraction or, rarely, sacrifice during surgery; results in temporary or permanent altered taste sensation (dysgeusia) or metallic taste, reported in 10–30% of cases depending on approach
• Lateral displacement (blunting): Particularly with the overlay technique; the graft migrates laterally, causing a blunted anterior recess and residual hearing deficit; manageable with revision surgery
• Inclusion cholesteatoma: Rare complication of the overlay technique when squamous epithelium is inadvertently buried under the graft

General Surgical Risks

• Anaesthesia risks (rare with modern techniques)
• Wound infection at the harvest site (temporalis or tragus)
• Temporary post-operative pain and swelling at harvest sites
• Keloid or hypertrophic scar formation at the post-auricular incision site (in predisposed patients)

Post-operative care is critical to optimize graft healing and hearing outcomes. Patients should receive clear written instructions from their surgeon.

Immediate Post-Operative Period (Days 1–7)

• Most patients are discharged the same day or after one overnight stay
• An ear packing or dressing (gelfoam, merocel, or an external dressing) is placed at the time of surgery and is typically removed at the first post-operative visit (7–14 days)
• Mild pain is common; managed with oral analgesics (paracetamol, ibuprofen)
• Bloody or serosanguinous discharge from the ear is expected for the first 1–2 weeks
• Strictly avoid water entry into the ear: Cotton balls impregnated with petroleum jelly should be placed in the ear for showering; swimming is completely prohibited
• Nose blowing should be avoided for the first 3–4 weeks; if sneezing is inevitable, keep the mouth open to equalize pressure without Valsalva
• Air travel should be avoided for 2–4 weeks post-operatively depending on surgeon preference; subsequent flights with a decongestant nasal spray during descent are recommended for 3–6 months

Intermediate Phase (Weeks 2–8)

• Ear packing removal at 7–14 days; the surgeon will inspect the graft status
• Continue water precautions (no swimming) until the surgeon confirms full healing — typically 6–8 weeks
• Audiometric follow-up at 6–8 weeks post-operatively to assess hearing improvement
• Avoid heavy lifting and strenuous exercise for 2–4 weeks to minimize Eustachian tube pressure changes

Long-Term Follow-Up

• Formal audiometry at 3 and 6 months to document hearing outcomes and air-bone gap closure
• Annual otoscopic examination to confirm ongoing graft integrity
• If graft failure (re-perforation) occurs, revision myringoplasty can be planned after achieving another 3–6 month dry period
• Patients who swim regularly should consider custom fitted ear defenders for 6–12 months after clearance from the surgeon

The cost of myringoplasty varies significantly by country, institution type, surgical approach, and whether it is performed under the public healthcare system or privately.

Approximate Cost Ranges

• India (private hospitals): INR 40,000–120,000 (approximately USD 480–1,440) including surgeon fees, anaesthesia, and a one-night hospital stay; endoscopic approaches may carry a premium; ENT centres of excellence in metropolitan areas may charge more
• India (government hospitals): Substantially subsidized or free for eligible patients under Ayushman Bharat PM-JAY and similar state health schemes
• United Kingdom (NHS): Free at point of care for NHS patients; waiting times may apply; privately, approximately GBP 2,000–4,500
• United States: USD 5,000–15,000 without insurance; typically covered under standard health insurance as a medically necessary procedure subject to deductibles and co-pays
• Australia: Covered under Medicare for public patients; private hospital gap fees apply under private health insurance
• Thailand / Medical Tourism: USD 1,500–4,000 at internationally accredited hospitals in Bangkok; popular destination for medical tourism in ENT surgery

Factors Influencing Cost

• Surgical approach: Endoscopic transcanal myringoplasty typically costs less than post-auricular microscopic approaches due to reduced operating time, no external incision, and potential for ambulatory surgery settings
• Graft material: Fat graft myringoplasty for small perforations is the least expensive; cartilage-perichondrium grafts may add to cost due to technical complexity
• Surgeon specialization: Neurotologists and subspecialty-trained otologists charge higher fees than general ENT surgeons
• Anaesthesia: General anaesthesia (required for children, preferred by many adults) is more expensive than local anaesthesia with sedation
• Revision surgery: More complex and expensive than primary myringoplasty due to scarring, altered anatomy, and need for wider access

Insurance Coverage

Myringoplasty is universally classified as a medically necessary surgical procedure for tympanic membrane perforation causing hearing loss or recurrent infection. It is covered by standard health insurance in most countries subject to pre-authorization, documentation of clinical indication, and the insurer's preferred provider network. Pre-authorization should be obtained before surgery, and the insurer should be supplied with the audiological evidence of air-bone gap and clinical documentation of failed conservative management.

Not all tympanic membrane perforations require surgical intervention. A range of management options exists depending on perforation size, symptoms, Eustachian tube function, and patient preference:

Conservative (Non-Surgical) Management

• Watchful waiting: Small traumatic perforations (less than 2 mm, especially post-barotrauma or post-perforation) spontaneously heal in 80–90% of cases within 4–12 weeks; observation with ear protection (water avoidance) is first-line management for fresh traumatic perforations
• Topical measures: Trichloroacetic acid (TCA) cauterization of the perforation edges and paper patch myringoplasty (office-based placement of a paper or Gelfoam patch) are minimally invasive measures that may promote healing for small, chronic perforations; success rates 60–75% for appropriately selected cases; no anaesthesia required
• Eustachian tube physiotherapy: Valsalva maneuver practice and nasal decongestants for Eustachian tube dysfunction may improve the chance of spontaneous healing in select patients

Office-Based Minimally Invasive Alternatives

• Fat graft myringoplasty: For small perforations (less than 2 mm diameter), harvest of a small amount of adipose tissue from the ear lobe and packing into the perforation under local anaesthesia in an outpatient clinic setting; success rates of 80–90% for appropriately selected cases; avoids general anaesthesia
• Butterfly inlay cartilage myringoplasty: Performed as an office procedure in selected patients under local anaesthesia; a cartilage butterfly graft is wedged into the perforation without a tympanomeatal flap; growing evidence supports comparable outcomes to formal surgery for medium perforations in cooperative adults

Hearing Rehabilitation Without Surgery

• Hearing aids: For patients who decline surgery, have failed repeated surgical attempts, or are medically unfit for surgery; modern behind-the-ear and receiver-in-canal hearing aids effectively compensate for the conductive hearing loss from a tympanic membrane perforation
• Bone-anchored hearing aids (BAHA): For patients with chronic non-reconstructible middle ear disease causing moderate-to-severe conductive hearing loss; implanted at the mastoid bone and conducts sound directly to the cochlea

The choice between observation, office-based procedures, formal myringoplasty, or hearing rehabilitation should be individualized by an otologist based on perforation characteristics, patient age, Eustachian tube function, hearing loss severity, lifestyle factors, and patient preference. Many small traumatic perforations will heal without any intervention.